AU3182999A - Methods of diagnosis and triage using cell activation measures - Google Patents
Methods of diagnosis and triage using cell activation measuresInfo
- Publication number
- AU3182999A AU3182999A AU31829/99A AU3182999A AU3182999A AU 3182999 A AU3182999 A AU 3182999A AU 31829/99 A AU31829/99 A AU 31829/99A AU 3182999 A AU3182999 A AU 3182999A AU 3182999 A AU3182999 A AU 3182999A
- Authority
- AU
- Australia
- Prior art keywords
- triage
- diagnosis
- methods
- cell activation
- activation measures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/038,894 US20030190368A1 (en) | 1998-03-11 | 1998-03-11 | Methods of diagnosis and triage using cell activation measures |
US09038894 | 1998-03-11 | ||
PCT/US1999/005247 WO1999046367A2 (en) | 1998-03-11 | 1999-03-11 | Methods of diagnosis and triage using cell activation measures |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3182999A true AU3182999A (en) | 1999-09-27 |
Family
ID=21902511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU31829/99A Abandoned AU3182999A (en) | 1998-03-11 | 1999-03-11 | Methods of diagnosis and triage using cell activation measures |
Country Status (6)
Country | Link |
---|---|
US (1) | US20030190368A1 (en) |
EP (1) | EP1062323A2 (en) |
JP (1) | JP2002505874A (en) |
AU (1) | AU3182999A (en) |
CA (1) | CA2322618A1 (en) |
WO (1) | WO1999046367A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4676608B2 (en) * | 1999-12-21 | 2011-04-27 | 武田薬品工業株式会社 | Novel tahikinin-like polypeptide and uses thereof |
AU2399601A (en) | 1999-12-21 | 2001-07-03 | Takeda Chemical Industries Ltd. | Novel tachykinin-like polypeptides and use thereof |
DE60323091D1 (en) | 2002-05-13 | 2008-10-02 | Arexis Ab | AUTOIMMUNE DISEASES AND NADPH OXIDASE DEFECTS |
JP2006348024A (en) * | 2005-05-17 | 2006-12-28 | Santen Pharmaceut Co Ltd | Neurocyte-protecting agent comprising amidino derivative as effective ingredient |
EP2143431A1 (en) * | 2005-05-17 | 2010-01-13 | Santen Pharmaceutical Co., Ltd. | Protective agent for neurocyte comprising amidino derivative as active ingredient |
JP2006348023A (en) * | 2005-05-17 | 2006-12-28 | Santen Pharmaceut Co Ltd | Vascularization inhibitor comprising amine derivative as effective ingredient |
ES2361932T3 (en) * | 2005-05-17 | 2011-06-24 | Santen Pharmaceutical Co., Ltd. | ANGIOGENESIS INHIBITOR CONTAINING AN AMINA DERIVATIVE AS ACTIVE INGREDIENT. |
WO2007013945A2 (en) * | 2005-07-20 | 2007-02-01 | The Regents Of The University Of California | Treating disorders associated with inflammation |
CA2646293C (en) * | 2006-03-15 | 2015-08-25 | The General Hospital Corporation | Devices and methods for detecting cells and other analytes |
JP5448317B2 (en) * | 2007-09-12 | 2014-03-19 | デンカ生研株式会社 | Method for reducing measurement error due to catalase inhibition by azide |
WO2010087874A1 (en) * | 2009-01-28 | 2010-08-05 | Anazyme, Llc | Compositions and methods for diagnosis of shock |
US8338127B2 (en) * | 2008-01-31 | 2012-12-25 | Anazyme | Testing a mammal for presence, progression or stage of a shock condition |
ES2945032T3 (en) | 2010-05-06 | 2023-06-28 | Charm Sciences Inc | Incubator device with reader |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
WO2013082458A1 (en) | 2011-12-02 | 2013-06-06 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
JP6509112B2 (en) * | 2012-07-03 | 2019-05-08 | プラブダ,ジェイ | Methods for the treatment, diagnosis and / or monitoring of the progression of oxo related conditions |
US20150276613A1 (en) * | 2012-10-25 | 2015-10-01 | Chrm Sciences, Inc. | Definitive development diagnostic analysis |
CA3085079A1 (en) | 2013-03-13 | 2014-10-02 | President And Fellows Of Harvard College | Stapled and stitched polypeptides and uses thereof |
CN105492460A (en) | 2013-06-14 | 2016-04-13 | 哈佛大学的校长及成员们 | Stabilized polypeptide insulin receptor modulators |
US10226566B2 (en) * | 2014-04-23 | 2019-03-12 | Genadyne Biotechnologies, Inc. | System and process for removing bodily fluids from a body opening |
CA2949535C (en) * | 2014-05-21 | 2023-09-12 | President And Fellows Of Harvard College | Ras inhibitory peptides and uses thereof |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
WO2019084186A1 (en) * | 2017-10-24 | 2019-05-02 | Leading BioSciences, Inc. | Compositions and methods for glucose control |
CN110715842A (en) * | 2019-11-15 | 2020-01-21 | 河北医科大学第三医院 | Use of D-PAS staining related reagent in diagnosis of liver injury |
CN111579763B (en) * | 2020-04-09 | 2023-04-07 | 北京博瑞世安科技有限公司 | Method for detecting respiratory function of leucocyte mitochondria and method for detecting kidney yin deficiency |
CN117825673B (en) * | 2024-03-04 | 2024-05-10 | 迈赛凯尔(山东)生命科学有限公司 | Exosome detection device |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5550139A (en) * | 1994-01-03 | 1996-08-27 | The Wichita State University | Serine protease inhibitors |
US5447957A (en) * | 1994-06-02 | 1995-09-05 | Smithkline Beecham Corp. | Anti-inflammatory compounds |
US5917013A (en) * | 1995-12-06 | 1999-06-29 | Simon W. Rabkin | Peptides and their use to ameliorate cell death |
WO1999015891A1 (en) * | 1997-09-25 | 1999-04-01 | The Regents Of The University Of California | System and method for measuring hydrogen peroxide levels in a fluid and method for assessing oxidative stress |
-
1998
- 1998-03-11 US US09/038,894 patent/US20030190368A1/en not_active Abandoned
-
1999
- 1999-03-11 AU AU31829/99A patent/AU3182999A/en not_active Abandoned
- 1999-03-11 JP JP2000535734A patent/JP2002505874A/en not_active Withdrawn
- 1999-03-11 EP EP99913843A patent/EP1062323A2/en not_active Withdrawn
- 1999-03-11 WO PCT/US1999/005247 patent/WO1999046367A2/en not_active Application Discontinuation
- 1999-03-11 CA CA002322618A patent/CA2322618A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2322618A1 (en) | 1999-09-16 |
WO1999046367A8 (en) | 2000-01-13 |
WO1999046367A3 (en) | 1999-12-09 |
US20030190368A1 (en) | 2003-10-09 |
EP1062323A2 (en) | 2000-12-27 |
WO1999046367A2 (en) | 1999-09-16 |
JP2002505874A (en) | 2002-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3182999A (en) | Methods of diagnosis and triage using cell activation measures | |
AU6409799A (en) | Tissue analysis and kits therefor | |
AU7612196A (en) | Functional human hematopoietic cells | |
AU4543099A (en) | Sandwich arrays and methods of making and using the same | |
AU2569599A (en) | Cells or tissues with increased protein factors and methods of making and using same | |
AU3908697A (en) | Anodizing electrolyte and its use | |
AU7362998A (en) | Solid state electrochemical sensors and methods of making the same | |
AU5234698A (en) | An ultrasound system and methods utilizing same | |
AU6763898A (en) | Gel sensors and methods of use thereof | |
AU5301598A (en) | Detection of analytes using electrochemistry | |
AU7713598A (en) | Skin pricker | |
AU5482599A (en) | Human mesencephalon cell lines and methods of use therefor | |
AU2361695A (en) | Red blood cell surrogate | |
AU4998600A (en) | Airway-based cardiac output monitor and methods for using same | |
AU6184396A (en) | Solid oral diagnostic test meal and methods of use thereof | |
AU2871899A (en) | Human receptor proteins; related reagents and methods | |
AU9301998A (en) | Composition and methods using galectin-1 | |
AU5923998A (en) | 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same | |
AU2087799A (en) | Diagnostic and therapeutic methods based upon valpha24jalphaq t cells | |
AU4202699A (en) | Human socs proteins | |
AU2667197A (en) | Stabilized preparations of human troponins and modifications thereof, diagnostic assay methods and assay kits | |
AU6491699A (en) | Biosensor cell device and its use | |
AU4150999A (en) | Method and kit for early diagnosis of cancer | |
AU1524095A (en) | Ex vivo activation of immune cells | |
AU4565697A (en) | Analysis of carbohydrates |